ArticleCancer immunology, immunotherapy : CII2024

Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.

Domenico Mallardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.